22-Oxacalcitriol ameliorates high-turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritis

scientific article published on 01 December 1999

22-Oxacalcitriol ameliorates high-turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritis is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1043666734
P356DOI10.1046/J.1523-1755.1999.00772.X
P698PubMed publication ID10594779

P50authorMasafumi FukagawaQ56997226
P2093author name stringK Endo
T Masaki
K Kurokawa
M Hirata
N Koike
K Tsunemi
K Katsumata
H Ohkawa
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)2040-2047
P577publication date1999-12-01
P1433published inKidney InternationalQ6404823
P1476title22-Oxacalcitriol ameliorates high-turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritis
P478volume56

Reverse relations

cites work (P2860)
Q36029282Are new vitamin D analogues in renal bone disease superior to calcitriol?
Q36138126Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial
Q79761766Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism
Q36712981Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease
Q45714070Effects of vitamin D analog, 22-oxa-1,25-dihydroxyvitamin D(3), on bone reconstruction by vascularized bone allograft
Q83144788Initial parathyroid surgery in 606 patients with renal hyperparathyroidism
Q36947028Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease
Q33600519PDK1-FoxO1 pathway in AgRP neurons of arcuate nucleus promotes bone formation via GHRH-GH-IGF1 axis